Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by europe10on Mar 13, 2014 9:28am
212 Views
Post# 22317472

RE:Can someone please explain?

RE:Can someone please explain?
Snoopydoo01, before Nov 14th, it was clearly communicated from the company that FDA approval was in the bag.
So i was priced in. (You write it was exptected to jump 3-5 times but that was just talk without any validity ) Next attempt they manage FDA approval, but with reduced credibilty in the market place AND without any cash = larger PP and dilution. And during the period they have with Europen and Canadian approval sold 0 products.
From here there are many question marks. Price around current levels appear about correct.
Upside short term is a partner (very unlikely) or that US investors suddenly wake up (still unliklely but far from impossible)
Longer term - 1-2 years - this might be a dougle or triple from here.
If against all odds it would suddenly awake and run up close to 20 cents almost all investors would sell/reduce. There is a significant opportunity cost staying invested in VPT as upcoming  financing will most likely keep the stock down for months/quarters
Bullboard Posts